These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11053913)

  • 1. Unraveling the patterns of subclinical pheomelanin-enriched facial hyperpigmentation: effect of depigmenting agents.
    Hermanns JF; Petit L; Martalo O; Piérard-Franchimont C; Cauwenbergh G; Piérard GE
    Dermatology; 2000; 201(2):118-22. PubMed ID: 11053913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a soy moisturizer in photoaging: a double-blind, vehicle-controlled, 12-week study.
    Wallo W; Nebus J; Leyden JJ
    J Drugs Dermatol; 2007 Sep; 6(9):917-22. PubMed ID: 17941363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of topical hypopigmenting agents on solar lentigines of Asian women.
    Hermanns JF; Petit L; Piérard-Franchimont C; Paquet P; Piérard GE
    Dermatology; 2002; 204(4):281-6. PubMed ID: 12077522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.
    Hakozaki T; Minwalla L; Zhuang J; Chhoa M; Matsubara A; Miyamoto K; Greatens A; Hillebrand GG; Bissett DL; Boissy RE
    Br J Dermatol; 2002 Jul; 147(1):20-31. PubMed ID: 12100180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
    Bruce S
    J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging.
    Fabi SG; Goldman MP
    J Drugs Dermatol; 2013 Mar; 12(3):S32-7. PubMed ID: 23545931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in facial hyperpigmentation after treatment with a combination of topical niacinamide and tranexamic acid: a randomized, double-blind, vehicle-controlled trial.
    Lee DH; Oh IY; Koo KT; Suk JM; Jung SW; Park JO; Kim BJ; Choi YM
    Skin Res Technol; 2014 May; 20(2):208-12. PubMed ID: 24033822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
    Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
    J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional variability in mottled subclinical melanoderma in the elderly.
    Petit L; Fogouang L; Uhoda I; Smitz S; Piérard-Franchimont C; Piérard GE
    Exp Gerontol; 2003 Mar; 38(3):327-31. PubMed ID: 12581798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal and abnormal skin color.
    Ortonne JP
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S125-9. PubMed ID: 23522626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation.
    Desai S; Ayres E; Bak H; Manco M; Lynch S; Raab S; Du A; Green D; Skobowiat C; Wangari-Talbot J; Zheng Q
    J Drugs Dermatol; 2019 May; 18(5):454-459. PubMed ID: 31141852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The depigmenting effect of RALGA in C57BL/6 mice.
    Kasraee B; Tran C; Sorg O; Saurat JH
    Dermatology; 2005; 210 Suppl 1():30-4. PubMed ID: 15724105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of topical depigmenting agent in healthy human fair skin female volunteers: A single-arm study.
    Shah S; Chew SK
    J Cosmet Dermatol; 2018 Oct; 17(5):830-839. PubMed ID: 29193788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of two commercial hyperpigmentation kits in the treatment of facial hyperpigmentation and photo-aging.
    Fabi S; Massaki N; Goldman MP
    J Drugs Dermatol; 2012 Aug; 11(8):964-8. PubMed ID: 22859242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal of facial pigmentary unit and facial hyperpigmentation type for Fitzpatrick skin types II-IV.
    Oh SM; Lee YE; Ko MJ; Baek JH; Shin MK
    Skin Res Technol; 2023 Jan; 29(1):e13251. PubMed ID: 36478452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical speckled perifollicular melanosis of the scalp.
    Petit L; Claudine ; Piérard-Franchimont ; Saint Léger D; Loussouarn G; Piérard GE
    Eur J Dermatol; 2002; 12(6):565-8. PubMed ID: 12459529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway.
    Paine C; Sharlow E; Liebel F; Eisinger M; Shapiro S; Seiberg M
    J Invest Dermatol; 2001 Apr; 116(4):587-95. PubMed ID: 11286627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey and mechanism of skin depigmenting and lightening agents.
    Parvez S; Kang M; Chung HS; Cho C; Hong MC; Shin MK; Bae H
    Phytother Res; 2006 Nov; 20(11):921-34. PubMed ID: 16841367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound enhanced skin-lightening effect of vitamin C and niacinamide.
    Hakozaki T; Takiwaki H; Miyamoto K; Sato Y; Arase S
    Skin Res Technol; 2006 May; 12(2):105-13. PubMed ID: 16626384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The depigmenting effect of natural resorcinol type polyphenols Kuwanon O and Sanggenon T from the roots of morus australis.
    Hu S; Zheng Z; Chen F; Wang M
    J Ethnopharmacol; 2017 Jan; 195():196-203. PubMed ID: 27851907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.